Is a neuropeptide the same thing as a supplement?
No. Neuropeptide describes a short amino-acid chain involved in nervous-system signaling. It does not establish a supplement category, an approved use or safety. Semax, Selank and DSIP have no FDA-approved drug products.
Does “nootropic” describe one kind of medicine?
Online it is a broad marketing label around mental performance, rather than one established drug class for these compounds. A label cannot establish a common mechanism or replace a human clinical study.
What is the difference between Semax and Selank?
Semax’s design begins with part of ACTH, a hormone involved in the stress response. Selank’s begins with tuftsin, an immune-related peptide. The component comparison explains their different research histories.
Can the components be requested separately through this route?
Promise Peptides offers these ingredients only together as the Semax and Selank blend.
Has the blend been shown to sharpen memory?
Component research does not establish that outcome for the blend. Animal measurements, small brain-scan studies and anxiety studies address different questions. They do not demonstrate a dependable everyday memory benefit from the combined product.
Why is DSIP’s name so confident?
It reflects the electrical sleep patterns in the early rabbit experiments. The later review of its biology found the proposed sleep role weakly supported. A specific receptor and production pathway remain unresolved.
Does a study using human blood count as a clinical trial?
No. A study outside the body can use human serum and still be a laboratory experiment. It can identify an interaction without showing a treatment effect or measuring safety in patients.
What does a placebo comparison add?
A placebo is an inactive treatment used for comparison. It helps estimate changes related to expectations or the study setting. Without it, a reported improvement cannot confidently be assigned to the substance being investigated.
What FDA review do compounded medicines receive?
These medicines are compounded for prescriptions and are not FDA-approved. The FDA does not review compounded medicines before marketing for safety, effectiveness or quality. That includes the compounded blend and DSIP, even when a licensed provider prescribes them.
Does LegitScript certification change a medicine’s approval?
The Promise service carries certification from LegitScript. The certification applies to the service; it does not give a compounded medicine FDA approval or establish a clinical result.
Who decides whether a request leads to treatment?
A licensed U.S. provider reviews every Promise request and makes the prescribing decision. Some readers will not be eligible for treatment through this service. The service is for U.S. patients, and availability differs by state and treatment. Prescriptions go to licensed compounding pharmacies in the United States for preparation.
Are other medicines and pregnancy relevant to the review?
Yes. Long-term safety and interactions are inadequately characterized, and pregnancy and breastfeeding lack adequate safety evidence. Personal medical questions require a provider’s assessment. Neurotech cannot decide whether a treatment is appropriate for an individual.